Ajanta Pharma

BSE: 532331 | NSE: AJANTPHARM
Ajanta Pharma (CIN: L24230MH1979PLC022059) operates in the Pharmaceuticals industry and has been listed in the stock market since 5th Jun 2000. It currents trades on NSE with symbol AJANTPHARM and on BSE with scrip code 532331.
The registered office of the company is Ajanta House, Charkop, Kandivli (W),Mumbai,Maharashtra,400067.

The management team of Ajanta Pharma is led by Mr. Mannalal B. Agrawal who is the Non-Executive - Non Independent Director-Chairperson related to Promoter. Other members of the management team consist of Mr. Madhusudan B. Agrawal (Designation:Executive Director), Arvind K Agrawal (Designation:Chief Financial Officer), Mr. Yogesh M. Agrawal (Designation:Executive Director), Mr. Rajesh M.Agrawal (Designation:Executive Director), Mr. Chandrakant Khetan (Designation:Non-Executive - Independent Director), Mr. K H. Viswanathan (Designation:Non-Executive - Independent Director), Mr. Prabhakar Dalal (Designation:Non-Executive - Independent Director), Mrs. Anjana Grewal (Designation:Non-Executive - Independent Director), Gaurang Shah (Designation:Company Secretary & Compliance Officer), .

The price and other financial information of Ajanta Pharma is as below -

BSE 1562.75 -52.7 (-3.26%)

BSE

1562.75 -52.7 (-3.26%)
Volume: 24,567.00
M. Cap: 13,635.00
P/E: 31.28
Prev. Close: 1,615.45
Day
52 Wk
Symbol is not Traded Today for NSE

Stock Price Chart

Shareholding Pattern

Category No. of shares Percent(%)
Promoters 6,15,28,601 70.51
Foreign Institutions 71,82,841 8.23
NBFC and Mutual Funds 82,95,202 9.51
Central Government 6,41,485 0.74
Others 9,38,951 1.08
General Public 73,42,988 8.41
Financial Institutions 13,31,202 1.53
Total 8,72,61,270 100.01

Financial Data

Consolidated
Figures in crore 2020 2019 2018
Net Sales 2,587.87 2,055.37 2,125.76
Operating Profit 771.60 587.51 682.55
Other Income 92.19 21.08 24.16
Interest 11.91 1.16 0.41
Depreciation 95.72 72.08 59.59
Profit Before Tax 663.97 514.27 622.55
Tax 196.27 127.30 153.91
Profit After Tax 467.70 386.97 468.64
Share Capital 17.54 17.54 17.69
Reserves 2,581.33 2,227.67 2,023.68
Net Worth 2,598.87 2,245.21 2,041.37
Loans 77.43 49.73 14.96
Gross Block 1,974.61 1,593.35 1,417.23
Investments 79.42 77.73 189.96
Cash 205.25 100.51 93.09
Debtors 775.30 459.48 459.79
Net Working Capital 992.88 777.37 752.38
Operating Profit Margin (%) 29.82 28.58 32.11
Net Profit Margin (%) 18.07 18.83 22.05
Earning Per Share (Rs) 53.33 44.12 52.98
Dividend (%) 650.00 450.00 0.00
Dividend Payout 113.44 79.22 0.00
Standalone
Figures in crore 2020 2019 2018
Net Sales 2,196.42 1,772.62 1,825.35
Operating Profit 713.06 583.36 619.82
Other Income 184.20 102.15 73.01
Interest 9.10 0.41 0.24
Depreciation 91.29 69.90 57.14
Profit Before Tax 612.67 513.05 562.44
Tax 171.54 121.29 134.92
Profit After Tax 441.13 391.76 427.52
Share Capital 17.54 17.54 17.69
Reserves 2,443.76 2,124.54 1,913.81
Net Worth 2,461.30 2,142.08 1,931.50
Loans 31.75 13.77 13.16
Gross Block 1,925.10 1,555.61 1,379.38
Investments 85.77 83.00 200.64
Cash 87.85 35.87 38.67
Debtors 734.24 423.38 432.19
Net Working Capital 826.90 649.54 646.00
Operating Profit Margin (%) 32.46 32.91 33.96
Net Profit Margin (%) 20.08 22.10 23.42
Earning Per Share (Rs) 50.30 44.67 48.33
Dividend (%) 650.00 450.00 0.00
Dividend Payout 113.44 79.22 0.00
Dividend Declared (₹)
The company has declared dividend 15 times between 05 Sep 2001 and 15 Nov 2019, totaling Rs. 87.00 so far. The most recent dividend was declared on 15 Nov 2019 for Rs. 13.
Bonus History
Date Ratio
17 Sep 2013 issue 1:2

Financial Data Graph

The peers of Ajanta Pharma are AUROPHARMA, GLAXO and NECLIFE.

* The above data is collected from public sources and we do not guarantee the accuracy of the same.*

Popular Comments

No comment posted for this article.